Literature DB >> 25260315

Liver resection for HCC: patient's selection and controversial scenarios.

François Cauchy1, Olivier Soubrane1, Jacques Belghiti2.   

Abstract

Liver resection is a valuable curative option for patients with hepatocellular carcinoma (HCC). Yet, the balance between the operative risk following hepatectomy for HCC occurring on chronic liver disease and the oncologic prognosis of advanced lesions have led treatment recommendations to limiting the place of liver resection to selected patients with preserved liver function harbouring early-stage tumours. However, better understanding of the natural history of both tumour and underlying liver disease, sophisticated assessment of the liver function, improvements in the preoperative management of the patients with the use of liver volume modulation, refinements in surgical technique including anatomic resection and laparoscopic approach along with tailored management of recurrences have led expert centres to better define and extend the indications for liver resection. In this setting, the reported favourable operative results and long-term outcomes following resection of HCC in a number of controversial scenarios support that current guidelines could be refined.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Adjuvant therapy; Chronic liver disease; Hepatocellular carcinoma; Liver resection; Patient's selection; Preoperative management; Recurrence

Mesh:

Year:  2014        PMID: 25260315     DOI: 10.1016/j.bpg.2014.08.013

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  17 in total

1.  Global Phosphoproteomic Analysis Reveals Significant Metabolic Reprogramming in the Termination of Liver Regeneration in Mice.

Authors:  Jingzi Zhang; Neng Tang; Yinjuan Zhao; Ruoyu Zhao; Xiao Fu; Dandan Zhao; Yue Zhao; Lan Huang; Chaojun Li; Yudong Qiu; Bin Xue; Lei Fang
Journal:  J Proteome Res       Date:  2020-03-10       Impact factor: 4.466

2.  Treatment of hepatocellular carcinoma in the community: disparities in standard therapy.

Authors:  Linda C Harlan; Helen M Parsons; Charles L Wiggins; Jennifer L Stevens; Yehuda Z Patt
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

Review 3.  Strategies to increase the resectability of hepatocellular carcinoma.

Authors:  Wong Hoi She; Kenneth Sh Chok
Journal:  World J Hepatol       Date:  2015-08-28

4.  Downregulated connexin32 promotes EMT through the Wnt/β-catenin pathway by targeting Snail expression in hepatocellular carcinoma.

Authors:  Yan Yang; Na Zhang; Jian Zhu; Xiao-Ting Hong; Hao Liu; Yu-Rong Ou; Fang Su; Rui Wang; Yu-Mei Li; Qiong Wu
Journal:  Int J Oncol       Date:  2017-05-08       Impact factor: 5.650

5.  Integration of Child-Pugh score with future liver remnant yields improved prediction of liver dysfunction risk for HBV-related hepatocellular carcinoma following hepatic resection.

Authors:  Heng Zou; Yiming Tao; Zhi-Ming Wang
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

6.  External Radiation versus Internal Radiation for Patients with Advanced Unresectable HCC -A SEER Based Study.

Authors:  Xuan Wang; Mo Chen; Ran Wei; Zheng Wang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

7.  Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.

Authors:  Hsueh-Chou Lai; Chun-Chieh Yeh; Long-Bin Jeng; Shang-Fen Huang; Pei-Ying Liao; Fu-Ju Lei; Wei-Chun Cheng; Cheng-Lung Hsu; Xiujun Cai; Chawnshang Chang; Wen-Lung Ma
Journal:  Oncotarget       Date:  2016-07-19

8.  Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival.

Authors:  Aya Nomura; Masatoshi Ishigami; Takashi Honda; Teiji Kuzuya; Yoji Ishizu; Takanori Ito; Hideya Kamei; Yasuharu Onishi; Yasuhiro Ogura; Mitsuhiro Fujishiro
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

Review 9.  Simultaneous curative resection of double colorectal carcinoma with synchronous bilobar liver metastases.

Authors:  Emilio De Raffele; Mariateresa Mirarchi; Dajana Cuicchi; Ferdinando Lecce; Claudio Ricci; Riccardo Casadei; Bruno Cola; Francesco Minni
Journal:  World J Gastrointest Oncol       Date:  2018-10-15

10.  End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma.

Authors:  Fan-Hua Kong; Xiong-Ying Miao; Heng Zou; Li Xiong; Yu Wen; Bo Chen; Xi Liu; Jiang-Jiao Zhou
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.